PAPER Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW,
SEARCH RESULTS
331743 RESULTS
PAPER Toga AW, Crawford KL,
The informatics core of the Alzheimer's Disease Neuroimaging Initiative.
Alzheimers Dement. 2010 May;6(3):247-56. PubMed: 20451873PAPER Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, Kuo JH,
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes.
Alzheimers Dement. 2010 May;6(3):257-64. PubMed: 20451874PAPER Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR, Weiner MW,
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Alzheimers Dement. 2010 May;6(3):265-73. PubMed: 20451875PAPER Schmidt ME, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board.
Alzheimers Dement. 2010 May;6(3):286-90. PubMed: 20451878PAPER Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D,
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Alzheimers Dement. 2010 May;6(3):291-6. PubMed: 20451879PAPER Iwatsubo T
Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.
Alzheimers Dement. 2010 May;6(3):297-9. PubMed: 20451880PAPER Guo AJ, Xie HQ, Choi RC, Zheng KY, Bi CW, Xu SL, Dong TT, Tsim KW
Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
Chem Biol Interact. 2010 Sep 6;187(1-3):246-8. PubMed: 20452337PAPER Simmons-Stern NR, Budson AE, Ally BA
Music as a memory enhancer in patients with Alzheimer's disease.
Neuropsychologia. 2010 Aug;48(10):3164-7. PubMed: 20452365PAPER Ryan DA, Narrow WC, Federoff HJ, Bowers WJ
An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies.
J Neurosci Methods. 2010 Jul 15;190(2):171-9. PubMed: 20452375PAPER Liu M, Wu G, Baysarowich J, Kavana M, Addona GH, Bierilo KK, Mudgett JS, Pavlovic G, Sitlani A, Renger JJ, Hubbard BK, Fisher TS, Zerbinatti CV
PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain.
J Lipid Res. 2010 Sep;51(9):2611-8. PubMed: 20453200PAPER Blalock EM, Phelps JT, Pancani T, Searcy JL, Anderson KL, Gant JC, Popovic J, Avdiushko MG, Cohen DA, Chen KC, Porter NM, Thibault O
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
PLoS One. 2010;5(4):e10405. PubMed: 20454453PAPER Shen L, Saykin AJ, Kim S, Firpi HA, West JD, Risacher SL, McDonald BC, McHugh TL, Wishart HA, Flashman LA
Comparison of manual and automated determination of hippocampal volumes in MCI and early AD.
Brain Imaging Behav. 2010 Mar;4(1):86-95. PubMed: 20454594PAPER Paul S, Planque S, Nishiyama Y
Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.
J Clin Immunol. 2010 May;30 Suppl 1:S43-9. PubMed: 20454852PAPER Kreutzmann P, Wolf G, Kupsch K
Minocycline recovers MTT-formazan exocytosis impaired by amyloid beta peptide.
Cell Mol Neurobiol. 2010 Oct;30(7):979-84. PubMed: 20455019Current Filters
No filters selected